國立高雄大學圖資館 |

登入

回首頁

Pharmacotherapy for liver cirrhosis and its complications

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Pharmacotherapy for liver cirrhosis and its complicationsedited by Xingshun Qi, Yongping Yang.
其他作者:	Qi, Xingshun.
出版者:	Singapore :Springer Nature Singapore :2022.
面頁冊數:	xii, 240 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	LiverCirrhosis
電子資源:	https://doi.org/10.1007/978-981-19-2615-0
ISBN:	9789811926150$q(electronic bk.)

Pharmacotherapy for liver cirrhosis and its complications
Pharmacotherapy for liver cirrhosis and its complications[electronic resource] /edited by Xingshun Qi, Yongping Yang. - Singapore :Springer Nature Singapore :2022. - xii, 240 p. :ill., digital ;24 cm.

Anti-HBV drugs in liver cirrhosis -- Anti-HCV drugs in liver cirrhosis -- Anticoagulants in liver cirrhosis -- Antibiotics in liver cirrhosis -- Silymarin in liver cirrhosis -- Ursodeoxycholic acid in liver cirrhosis -- Emricasan in liver cirrhosis -- Non-selective beta blockers in liver cirrhosis -- Somatostatin and octreotide in liver cirrhosis -- Terlipressin in liver cirrhosis -- Diuretics in liver cirrhosis -- Statins in liver cirrhosis -- L-Ornithine L-Aspartate in liver cirrhosis -- Lactulose in liver cirrhosis.

This book aims to provide an updated information on different types of major and emerging drugs for managing liver cirrhosis and its complications, including acute gastroesophageal variceal bleeding, ascites, hepatic encephalopathy, liver failure, acute kidney injury, and portal venous thrombosis. The chapters are organized by drug class, such as anti-HBV drugs, anti-HCV drugs, anticoagulants, and antibiotics, etc. The clinical efficacy, indication, and contra-indication of the various drug therapies are discussed using supportive reference material from authoritative sources and published clinical trials. It will be an invaluable reference for physicians who are treating patients with liver cirrhosis, especially those presenting with acute life-threatening complications.

ISBN: 9789811926150$q(electronic bk.)

Standard No.: 10.1007/978-981-19-2615-0doiSubjects--Topical Terms:

932096
Liver
--Cirrhosis

LC Class. No.: RC848.C5 / P43 2022

Dewey Class. No.: 616.3624

Pharmacotherapy for liver cirrhosis and its complications
LDR:02298nmm a2200325 a 4500 001 627879
003 DE-He213
005 20220726125453.0
006 m d
007 cr nn 008maaau
008 230201s2022 si s 0 eng d
020 $a 9789811926150$q(electronic bk.)
020 $a 9789811926143$q(paper)
024 7 $a 10.1007/978-981-19-2615-0 $2 doi
035 $a 978-981-19-2615-0
040 $a GP $c GP
041 0 $a eng
050 4 $a RC848.C5 $b P43 2022
072 7 $a MJ $2 bicssc
072 7 $a MED045000 $2 bisacsh
072 7 $a MJ $2 thema
082 0 4 $a 616.3624 $2 23
090 $a RC848.C5 $b P536 2022
245 0 0 $a Pharmacotherapy for liver cirrhosis and its complications $h [electronic resource] / $c edited by Xingshun Qi, Yongping Yang.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2022.
300 $a xii, 240 p. : $b ill., digital ; $c 24 cm.
505 0 $a Anti-HBV drugs in liver cirrhosis -- Anti-HCV drugs in liver cirrhosis -- Anticoagulants in liver cirrhosis -- Antibiotics in liver cirrhosis -- Silymarin in liver cirrhosis -- Ursodeoxycholic acid in liver cirrhosis -- Emricasan in liver cirrhosis -- Non-selective beta blockers in liver cirrhosis -- Somatostatin and octreotide in liver cirrhosis -- Terlipressin in liver cirrhosis -- Diuretics in liver cirrhosis -- Statins in liver cirrhosis -- L-Ornithine L-Aspartate in liver cirrhosis -- Lactulose in liver cirrhosis.
520 $a This book aims to provide an updated information on different types of major and emerging drugs for managing liver cirrhosis and its complications, including acute gastroesophageal variceal bleeding, ascites, hepatic encephalopathy, liver failure, acute kidney injury, and portal venous thrombosis. The chapters are organized by drug class, such as anti-HBV drugs, anti-HCV drugs, anticoagulants, and antibiotics, etc. The clinical efficacy, indication, and contra-indication of the various drug therapies are discussed using supportive reference material from authoritative sources and published clinical trials. It will be an invaluable reference for physicians who are treating patients with liver cirrhosis, especially those presenting with acute life-threatening complications.
650 0 $a Liver $x Cirrhosis $x Chemotherapy. $3 932096
650 0 $a Liver $x Cirrhosis $x Chemotherapy $x Complications. $3 932097
650 1 4 $a Internal Medicine. $3 273839
700 1 $a Qi, Xingshun. $3 861814
700 1 $a Yang, Yongping. $3 932095
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-19-2615-0
950 $a Medicine (SpringerNature-11650)